Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer
Viktoria Florentine Koehler, Pia Adam, Karin Frank‐Raue, et al.
Thyroid (2020) Vol. 31, Iss. 3, pp. 459-469
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
Tobiloba Elebiyo, Damilare Rotimi, Ikponmwosa Owen Evbuomwan, et al.
Cancer Treatment and Research Communications (2022) Vol. 32, pp. 100620-100620
Open Access | Times Cited: 89
Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
Giuseppe Lisco, Anna De Tullio, Emilio Jirillo, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 9, pp. 1801-1814
Open Access | Times Cited: 100
Current Guidelines for Management of Medullary Thyroid Carcinoma
Mijin Kim, Bo Hyun Kim
Endocrinology and Metabolism (2021) Vol. 36, Iss. 3, pp. 514-524
Open Access | Times Cited: 64
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
Antonio Matrone, Carla Gambale, Alessandro Prete, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 33
Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study
Mijin Kim, Meihua Jin, Min Ji Jeon, et al.
Thyroid (2022) Vol. 33, Iss. 1, pp. 91-99
Closed Access | Times Cited: 32
Metastatic medullary thyroid carcinoma: a new way forward
Anna Angelousi, Aimee R. Hayes, Eleftherios Chatzellis, et al.
Endocrine Related Cancer (2022) Vol. 29, Iss. 7, pp. R85-R103
Open Access | Times Cited: 29
Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect
Linnea Højer Wang, Markus Wehland, Petra M. Wise, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2312-2312
Open Access | Times Cited: 22
Novel Inhibitor-Based Therapies for Thyroid Cancer—An Update
Maciej Ratajczak, Damian Gaweł, Marlena Godlewska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11829-11829
Open Access | Times Cited: 36
Targeted therapy and drug resistance in thyroid cancer
Yujie Zhang, Zhichao Xing, Tianyou Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114500-114500
Closed Access | Times Cited: 26
Genetic Changes in Thyroid Cancers and the Importance of Their Preoperative Detection in Relation to the General Treatment and Determination of the Extent of Surgical Intervention—A Review
Jiří Hložek, Barbora Pekova, Jan Rotnágl, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1515-1515
Open Access | Times Cited: 25
A comprehensive overview of the relationship between RET gene and tumor occurrence
Lu Zhao, Na Wang, Dou Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
Yuxin Shen, Fengsheng Hong, Hualu Wu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Neuroendocrine Neoplasms of the Lungs, Thyroid, and Thymus
Barbara Buchalska, Małgorzata Solnik, Karol Maciejewski, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1028-1028
Open Access
Medullary thyroid carcinoma
Maria Alevizaki, Katerina Saltiki, Θεοδώρα Παππά, et al.
Elsevier eBooks (2025)
Closed Access
Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
Qi Liu, Wei Sun, Hao Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance
Katerina Saltiki, George Simeakis, Olga Karapanou, et al.
Endocrine (2023) Vol. 80, Iss. 3, pp. 570-579
Closed Access | Times Cited: 8
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Viktoria Florentine Koehler, Josefine Achterfeld, N. Sandner, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 14035-14043
Open Access | Times Cited: 8
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
Antonio Matrone, Alessandro Prete, Alice Nervo, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 10, pp. 2139-2151
Closed Access | Times Cited: 19
Precision oncology for RET-related tumors
Antonella Verrienti, Giorgio Grani, Marialuisa Sponziello, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: a cross-validated approach of ligand-based and structure-based molecular modeling studies
Suvankar Banerjee, Shristi Kejriwal, Balaram Ghosh, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 2, pp. 1047-1063
Open Access | Times Cited: 7
Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET
Nicolas Sahakian, Frédéric Castinetti, Pauline Romanet
Cancers (2023) Vol. 15, Iss. 19, pp. 4865-4865
Open Access | Times Cited: 7
Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer
Rohan Parikh, Lisa M. Hess, Elizabeth Esterberg, et al.
Thyroid Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Nanoparticles: Promising Auxiliary Agents for Diagnosis and Therapy of Thyroid Cancers
Eleonore Fröhlich, Richard Wahl
Cancers (2021) Vol. 13, Iss. 16, pp. 4063-4063
Open Access | Times Cited: 13
Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series
Viktoria Florentine Koehler, Carmina Teresa Fuß, Christina M. Berr, et al.
Clinical Endocrinology (2021) Vol. 96, Iss. 6, pp. 847-856
Open Access | Times Cited: 13
Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments
Rui Sousa Martins, Tito T. Jesus, Luís Cardoso, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1132-1132
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top